Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC) Meeting Abstract


Authors: Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; Lake, D.; Modi, S.; Traina, T. A.; Chen, M.; Patil, S.; Baselga, J.; Norton, L.; Hudis, C. A.; Dang, C. T.
Abstract Title: Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202406
PROVIDER: wos
Notes: Meeting Abstract: 633 -- Source: Wos
MSK Authors
  1. Sujata Patil
    383 Patil
  2. Clifford Hudis
    840 Hudis
  3. Larry Norton
    562 Norton
  4. Chau Dang
    156 Dang
  5. Diana E Lake
    70 Lake
  6. Monica Nancy Fornier
    136 Fornier
  7. Devika Gajria
    23 Gajria
  8. Elizabeth Comen
    47 Comen
  9. Tiffany A Traina
    153 Traina
  10. Shanu Modi
    132 Modi
  11. Julie Fasano
    9 Fasano
  12. Neil Mukund Iyengar
    63 Iyengar
  13. Jose T Baselga
    395 Baselga
  14. Melanie Fanny Chen
    6 Chen